Back to Browse Journals » Drug, Healthcare and Patient Safety » Volume 5

Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study

Authors Sato I, Akazawa M

Received 17 March 2013

Accepted for publication 13 May 2013

Published 24 June 2013 Volume 2013:5 Pages 143—150

DOI http://dx.doi.org/10.2147/DHPS.S45347

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Izumi Sato,1 Manabu Akazawa2

1Department of Epidemiology and Statistics, Graduate School of Medicine, The University of Tokyo Tokyo, Japan; 2Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Tokyo, Japan

Background: The concomitant use of multiple medications by elderly patients with hypertension is a relatively common and growing phenomenon in Japan. This has been attributed to several factors, including treatment guidelines recommending prescription of multiple medications and a continuing increase in the elderly population with multiple comorbidities.
Objective: This study was aimed at investigating the association between polypharmacy, defined as the concomitant use of five or more medications, and risk of adverse drug reaction (ADR) in elderly Japanese hypertensive patients to examine the hypothesis that risk of ADR increases with the administration of an increasing number of co-medications.
Methods: Using a retrospective cohort design, the data regarding all hypertensive patients aged 65 years or older were extracted from the Risk/Benefit Assessment of Drugs – Analysis and Response Council antihypertensive medication database. The data were reviewed for classification of patients into one of three groups according to drug use at the initiation of therapy – a monotherapy group composed of patients who had taken the investigated drug only, a co-medication group composed of patients who had taken the investigated drug and a maximum of three other medications, and a polypharmacy group composed of patients who had taken the investigated drug and four or more other medications – and determination of the number of ADR events experienced. Estimated rate ratios (RRs) and 95% confidence intervals (CIs) were calculated using a Poisson regression model adjusted for drug category and patient age and sex. Various sensitivity analyses were performed to confirm the robustness of the study findings.
Results: Of 61,661 elderly Japanese patients (men, 41.8%; 75 years or older, 35.1%) registered in the database, 2491 patients (4.0%) experienced a total of 3144 ADR events during the study period. The rate of ADR per 10,000 person-days was 2.0 for the monotherapy group, 5.1 for the co-medication group, and 8.6 for the polypharmacy group. After adjusting for age, sex, and initial antihypertensive therapy, the RR was estimated at 2.4 (95% CI, 2.2–2.6) for the co-medication group and 4.3 (95% CI, 3.8–4.8) for the polypharmacy group, when compared with the monotherapy group.
Conclusion: The use of polypharmacy increases the risk of ADR among elderly Japanese patients with hypertension, calling for regular medication review to eliminate the administration of unnecessary co-medications.

Keywords: adverse drug reaction, antihypertensive, elderly, pharmacoepidemiology, polypharmacy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 

 

Readers of this article also read:

Synthesis, pharmacokinetics, and biological use of lysine-modified single-walled carbon nanotubes [Erratum]

Mulvey JJ, Feinberg EN, Alidori S, McDevitt MR, Heller DA, Scheinberg DA

International Journal of Nanomedicine 2015, 10:595-596

Published Date: 14 January 2015

Facing acid–base disorders in the third millennium – the Stewart approach revisited

Kishen R, Honoré PM, Jacobs R, Joannes-Boyau O, De Waele E, De Regt J, Van Gorp V, Boer W, Spapen HD

International Journal of Nephrology and Renovascular Disease 2014, 7:209-217

Published Date: 4 June 2014

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Recurrent furunculosis – challenges and management: a review

Ibler KS, Kromann CB

Clinical, Cosmetic and Investigational Dermatology 2014, 7:59-64

Published Date: 18 February 2014

Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature

Nasser M, Larsen TR, Waanbah B, Sidiqi I, McCullough PA

Drug, Healthcare and Patient Safety 2013, 5:191-198

Published Date: 26 September 2013

The economic burden of patient safety targets in acute care: a systematic review

Mittmann N, Koo M, Daneman N, McDonald A, Baker M, Matlow A, Krahn M, Shojanai KG, Etchells E

Drug, Healthcare and Patient Safety 2012, 4:141-165

Published Date: 5 October 2012

Lung microbiology and exacerbations in COPD

Beasley V, Joshi PV, Singanayagam A, Molyneaux PL, Johnston SL, Mallia P

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:555-569

Published Date: 31 August 2012